New York State Common Retirement Fund
OVID icon

New York State Common Retirement Fund’s Ovid Therapeutics OVID Stock Holding History

New York State Common Retirement Fund’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.2K Buy
+35,400
New +$91.3K ﹤0.01% 2722
2025
Q2 		– Sell
-18,986
Closed -$5.92K – 3302
2025
Q1 		$5.92K Hold
18,986
– – ﹤0.01% 3115
2024
Q4 		$17.7K Hold
18,986
– – ﹤0.01% 3061
2024
Q3 		$22.4K Hold
18,986
– – ﹤0.01% 3028
2024
Q2 		$14.6K Buy
18,986
+311
+2% +$865 ﹤0.01% 3227
2024
Q1 		$57K Sell
18,675
-307
-2% -$1.03K ﹤0.01% 2947
2023
Q4 		$61.1K Sell
18,982
-128
-0.7% -$438 ﹤0.01% 2939
2023
Q3 		$73.4K Sell
19,110
-7,690
-29% -$27.6K ﹤0.01% 2879
2023
Q2 		$87.9K Buy
+26,800
New +$91K ﹤0.01% 2957
2021
Q3 		– Sell
-378
Closed -$1K – 3472
2021
Q2 		$1K Sell
378
-38,622
-99% -$152K ﹤0.01% 3444
2021
Q1 		$157K Hold
39,000
– – ﹤0.01% 2920
2020
Q4 		$90K Sell
39,000
-200
-0.5% -$932 ﹤0.01% 3063
2020
Q3 		$225K Hold
39,200
– – ﹤0.01% 2595
2020
Q2 		$289K Buy
+39,200
New +$183K ﹤0.01% 2485
2019
Q2 		– Sell
-7,900
Closed -$14K – 3285
2019
Q1 		$14K Hold
7,900
– – ﹤0.01% 3140
2018
Q4 		$19K Hold
7,900
– – ﹤0.01% 3159
2018
Q3 		$45K Hold
7,900
– – ﹤0.01% 3111
2018
Q2 		$62K Hold
7,900
– – ﹤0.01% 3132
2018
Q1 		$56K Hold
7,900
– – ﹤0.01% 3022
2017
Q4 		$78K Hold
7,900
– – ﹤0.01% 3010
2017
Q3 		$68K Hold
7,900
– – ﹤0.01% 3042
2017
Q2 		$83K Buy
+7,900
New +$103K ﹤0.01% 3111

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

New York State Common Retirement Fund's OVID Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 35,400 shares worth $95.2K. The stake represents ﹤0.01% of the portfolio and ranks #2722 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in OVID as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in OVID in Q2 2017 and has held it in 22 quarters since. The position peaked at $289K in Q2 2020. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • New York State Common Retirement Fund held 35,400 shares of Ovid Therapeutics worth $95.2K as of Q2 2026.
  • Ovid Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2722 holding.
  • New York State Common Retirement Fund first reported a position in Ovid Therapeutics in Q2 2017 and has held it in 22 quarters since.
  • New York State Common Retirement Fund's Ovid Therapeutics position peaked at $289K in Q2 2020.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.